CMR Surgical

• CMR Surgical Versius Plus

  Versius

• 2025-04-04 - Financing round - >$200M - CMR Surgical closes financing round of more than $200M

  CMR Surgical announced the close of a financing round of more than $200 million, combining equity and debt to accelerate Versius commercialization, including its U.S. launch, and continued product development. - source: us.cmrsurgical.com

• 2021-06-28 - Series D - $600M - CMR Surgical closes $600M Series D at $3B valuation

  valuation: $3B - The company closed a source-verified historical financing round. - source: globenewswire.com

• Ally Bridge Group - Lead - Unknown - 1 funding event - first seen 2021-06-28
• Cambridge Innovation Capital - Lead - VC - 1 funding event - first seen 2021-06-28
• Chimera - Lead - Unknown - 1 funding event - first seen 2021-06-28
• GE Healthcare - Lead - Angel / Individual - 1 funding event - first seen 2021-06-28
• LGT - Lead - Corporate / CVC - 1 funding event - strategic/corporate - first seen 2021-06-28
• Lightrock - Lead - Unknown - 1 funding event - first seen 2021-06-28
• PFM Health Sciences - Lead - Unknown - 1 funding event - first seen 2021-06-28
• RPMI Railpen - Lead - Angel / Individual - 1 funding event - first seen 2021-06-28
• SoftBank Vision Fund 2 - Lead - VC - 1 funding event - first seen 2021-06-28
• Tencent - Lead - Unknown - 1 funding event - first seen 2021-06-28
• Trinity Capital - Participant - VC - 1 funding event - first seen 2025-04-04
• Watrium - Lead - Unknown - 1 funding event - first seen 2021-06-28

Events

• 2026-10-12 - Market Signal - CMR Surgical agrees proposed Stryker investment and U.S. alliance

  The agreement gives Stryker an exclusive option to acquire all CMR Surgical equity in the future. Stryker will serve as exclusive U.S. sales agent for the Versius portfolio. CMR Surgical will continue product development and commercialization outside the United States.

  Source
• 2026-07-22 - Demonstration - CMR Surgical announces an NVIDIA simulation workflow for Versius Plus

  The workflow uses NVIDIA Isaac for Healthcare’s Medical Physics Simulation framework and Cosmos-H-Dreams. CMR planned to showcase the simulation at the Society of Robotic Surgery conference in Florida on July 23–26, 2026. The simulation is for research and demonstration only and is not part of the currently cleared Versius Plus system or intended for clinical decision-making.

  Source
• 2026-07-09 - Regulatory - FDA records an open Class II recall for two Versius surgeon consoles

  The recall covers two V-SS-1020 consoles running Pratchett 1 version 62.1 that were distributed in California. The firm initiated the recall on June 9, 2026 and the corrective action is to notify customers and configure secure boot on the affected consoles. Updated instructions tell users to keep the system in a secure environment and inspect tamper-evident labels before use.

  Source
• 2026-04-29 - Regulatory - CMR Surgical submits Versius Plus 510(k) for benign gynecology

  The submission seeks clearance for benign procedures including total hysterectomy, oophorectomy and salpingectomy. CMR said the filing builds on global clinical experience and supports its U.S. market expansion. This is a premarket submission, not an FDA clearance; Versius Plus was previously cleared for adult cholecystectomy.

  Source
• 2026-03-26 - Production Milestone - CMR Surgical reports 45,000 patients treated with Versius

  The milestone spans general, colorectal, urology, gynaecology and thoracic procedures. CMR announced the total as it began introducing Versius Plus to U.S. surgeons after FDA clearance. Versius had been adopted by hospitals across more than 30 countries at the time of the announcement.

  Source
• 2026-01-08 - Regulatory - CMR Surgical receives CE and UKCA marks for Versius paediatric surgery

  The marks cover abdominal surgery in children and infants under 18. CMR said this was its first regulatory clearance for treating children. The release highlights Versius’ compact, modular design and small instruments for paediatric anatomy.

  Source
• 2025-12-16 - Regulatory - FDA clears Versius Plus for adult cholecystectomy

  The clearance covers robotically assisted cholecystectomy in adults aged 22 and older. Versius Plus remains surgeon-controlled and uses modular bedside arm units with an open console. CMR said U.S. commercialisation would begin in 2026.

  Source
• 2025-04-04 - Funding - CMR Surgical closes financing round of more than $200M

  The round closed with participation from existing investors and new investor Trinity Capital. CMR said proceeds will support global commercialization of Versius, with a focus on the U.S., and continued product development. CMR said Versius had completed more than 30,000 cases across more than 30 countries at the time of the announcement.

  Source
• 2025-01-14 - Executive Hire - CMR Surgical appoints Massimiliano Colella as Chief Executive Officer

  Colella joined CMR as Chief Commercial Officer in 2023. He had served as Interim Chief Executive Officer since October 2024. The appointment placed Colella as CEO and Board member as CMR continued expanding Versius globally.

  Source
• 2024-10-14 - Regulatory - CMR Surgical receives U.S. FDA marketing authorization for Versius

  The authorization was granted through the FDA De Novo process for a multi-port soft-tissue robotic-assisted surgical device. The stated U.S. indication was cholecystectomy for adults 22 and older who are eligible for soft-tissue minimal-access surgery. The source describes the first-generation Versius system, so this event is not attached to the tracked Versius Plus variant.

  Source
• 2024-09-03 - Org Change - CMR Surgical strengthens its senior team

  Bauman joined CMR’s executive leadership team with legal, corporate finance and mergers-and-acquisitions experience. Paknad joined to support global commercial efforts and brought experience in soft-tissue surgical robotics. The appointments strengthened CMR’s leadership capacity around Versius commercial growth.

  Source
• 2024-07-15 - Executive Hire - CMR Surgical appoints Daniel Moore as Non-Executive Chairman

  Moore’s role is to lead the CMR Surgical Board. The appointment places the Chair alongside CMR’s Board members and executive leadership. CMR said the leadership team would continue working to bring Versius to more hospitals and patients.

  Source
• 2021-06-28 - Funding - CMR Surgical closes $600M Series D at $3B valuation

  New investors included RPMI Railpen, Tencent and Chimera. LGT, Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare also participated. The capital supports global commercialization of Versius and development of CMR’s digital ecosystem.

  Source

Relationships

• NVIDIA

  Robotics Simulation Integration - CMR Surgical uses NVIDIA Cosmos-H simulation in Versius development.

• Stryker

  Partner - CMR and Stryker announced $400m preferred equity and an exclusive U.S. Versius sales alliance, subject to approvals and closing.

Comparable profiles

• Intuitive

  comparable profile - Robotic Assisted Surgery Builder

• Surgerii Robotics

  comparable profile - Robotic Assisted Surgery Builder

• Andromeda Surgical

  comparable profile - Robotic Assisted Surgery Builder

• LEM Surgical

  comparable profile - Robotic Assisted Surgery Builder

• Hellstern medical

  comparable profile - Robotic Assisted Surgery Builder

Shared workflows

• Panda Surgical

  workflow adjacency - Minimally Invasive Surgery · Surgical Robotics Companies

• Revolve Surgical

  workflow adjacency - Minimally Invasive Surgery · Surgical Robotics Companies

• Stereotaxis

  workflow adjacency - Surgical Robotics Companies

• PROCEPT BioRobotics

  workflow adjacency - Surgical Robotics Companies

• Microbot Medical

  workflow adjacency - Surgical Robotics Companies

• SS Innovations International

  workflow adjacency - Surgical Robotics Companies

• Vicarious Surgical

  workflow adjacency - Surgical Robotics Companies

• True Health Medical-B / 真健康医疗-B

  workflow adjacency - Surgical Robotics Companies

• ROBEAUTE

  workflow adjacency - Surgical Robotics Companies

• Nanoflex Robotics

  workflow adjacency - Surgical Robotics Companies

• Redefine Surgery

  workflow adjacency - Surgical Robotics Companies

• AiM Medical Robotics

  workflow adjacency - Surgical Robotics Companies

Context tags

• Robot-assisted procedure workflow - Workflow - Surgical robotics companies is a documented company focus.
• Robotic-assisted surgery builder - Peer Group - Robotic-assisted surgery builder is a documented company focus.
• Minimally invasive surgery - Workflow - Minimally invasive surgery is a documented company focus.